EXACT Historical Balance Sheet
EXAS Stock | USD 47.09 1.47 3.22% |
Trend analysis of EXACT Sciences balance sheet accounts such as Net Debt of 2.3 B or Cash of 630.9 M provides information on EXACT Sciences' total assets, liabilities, and equity, which is the actual value of EXACT Sciences to its prevalent stockholders. By breaking down trends over time using EXACT Sciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining EXACT Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether EXACT Sciences is a good buy for the upcoming year.
EXACT Sciences Inventory |
|
EXACT |
About EXACT Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of EXACT Sciences at a specified time, usually calculated after every quarter, six months, or one year. EXACT Sciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of EXACT Sciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which EXACT currently owns. An asset can also be divided into two categories, current and non-current.
EXACT Sciences Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of EXACT Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in EXACT Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of EXACT Sciences balance sheet. This account contains EXACT Sciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by EXACT Sciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from EXACT Sciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.At this time, EXACT Sciences' Other Stockholder Equity is comparatively stable compared to the past year. Total Liabilities is likely to gain to about 3.7 B in 2025, whereas Accumulated Other Comprehensive Income is likely to drop (991.2 K) in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Total Stockholder Equity | 3.0B | 3.1B | 2.4B | 2.5B | Total Assets | 6.2B | 6.5B | 5.9B | 6.2B |
EXACT Sciences balance sheet Correlations
Click cells to compare fundamentals
EXACT Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EXACT Sciences balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 4.9B | 6.7B | 6.2B | 6.5B | 5.9B | 6.2B | |
Total Stockholder Equity | 2.8B | 3.4B | 3.0B | 3.1B | 2.4B | 2.5B | |
Net Debt | (27.1M) | 2.0B | 2.2B | 1.9B | 2.2B | 2.3B | |
Cash | 1.5B | 315.5M | 242.5M | 605.4M | 600.9M | 630.9M | |
Other Assets | 20.3M | 63.8M | 74.6M | 36.7M | 42.2M | 44.3M | |
Cash And Short Term Investments | 1.8B | 1.0B | 632.1M | 777.6M | 1.0B | 1.1B | |
Common Stock Shares Outstanding | 151.1M | 171.3M | 176.4M | 180.1M | 184.2M | 193.4M | |
Liabilities And Stockholders Equity | 4.9B | 6.7B | 6.2B | 6.5B | 5.9B | 6.2B | |
Other Stockholder Equity | 4.3B | 6.0B | 6.3B | 6.6B | 6.9B | 7.2B | |
Total Liab | 2.1B | 3.3B | 3.2B | 3.3B | 3.5B | 3.7B | |
Total Current Assets | 2.2B | 1.4B | 982.3M | 1.2B | 1.6B | 1.6B | |
Other Current Liab | 267.2M | 423.3M | 306.3M | 356.5M | 366.1M | 384.4M | |
Total Current Liabilities | 575.8M | 517.1M | 412.7M | 514.7M | 732.2M | 768.8M | |
Property Plant And Equipment Net | 576.6M | 754.5M | 851.8M | 842.1M | 810.6M | 851.2M | |
Retained Earnings | (2.0B) | (2.6B) | (3.3B) | (3.5B) | (4.5B) | (4.3B) | |
Accounts Payable | 35.7M | 67.8M | 74.9M | 78.8M | 89.6M | 94.1M | |
Non Current Assets Total | 2.7B | 5.3B | 5.2B | 5.3B | 4.4B | 4.6B | |
Non Currrent Assets Other | (193.1M) | (451.3M) | (425.5M) | 177.4M | 169.7M | 178.2M | |
Common Stock Total Equity | 1.5M | 1.6M | 1.7M | 1.8M | 2.0M | 2.1M | |
Other Current Assets | 66.3M | 74.1M | 73.9M | 85.6M | 122.0M | 128.1M | |
Property Plant And Equipment Gross | 576.6M | 754.5M | 851.8M | 1.3B | 1.3B | 1.4B | |
Accumulated Other Comprehensive Income | 526K | (1.4M) | (5.2M) | 1.4M | (944K) | (991.2K) | |
Common Stock | 1.6M | 1.7M | 1.8M | 1.8M | 1.9M | 1.9M | |
Intangible Assets | 848.4M | 2.1B | 2.0B | 1.9B | 1.0B | 1.1B | |
Property Plant Equipment | 455.3M | 450.7M | 754.5M | 684.8M | 787.5M | 826.8M | |
Good Will | 1.2B | 2.3B | 2.3B | 2.4B | 2.4B | 2.5B | |
Other Liab | 28.1M | 61.6M | 417.8M | 345.1M | 396.8M | 416.7M | |
Short Term Investments | 348.7M | 715.0M | 389.6M | 172.3M | 437.1M | 234.4M | |
Non Current Liabilities Total | 1.5B | 2.8B | 2.8B | 2.8B | 2.8B | 2.9B | |
Current Deferred Revenue | 233.6M | 398.6M | 3.1M | 4.4M | 5.1M | 4.8M | |
Short Long Term Debt Total | 1.5B | 2.4B | 2.4B | 2.6B | 2.8B | 2.9B | |
Long Term Debt | 1.3B | 2.2B | 2.2B | 2.3B | 2.3B | 2.4B | |
Net Tangible Assets | (58.7M) | 737.4M | (1.0B) | 697.1M | 627.4M | 658.8M | |
Retained Earnings Total Equity | (1.1B) | (2.0B) | (2.6B) | (3.3B) | (2.9B) | (2.8B) | |
Capital Surpluse | 3.4B | 4.8B | 6.0B | 6.3B | 7.3B | 7.6B | |
Inventory | 92.3M | 105.0M | 118.3M | 127.5M | 162.4M | 170.5M | |
Non Current Liabilities Other | 61.6M | 417.8M | 352.5M | 336.0M | 315.5M | 331.3M | |
Short Term Debt | 330.2M | 25.9M | 31.6M | 79.4M | 276.6M | 290.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.